Kimberley A. Elting
CIK 1605209 · President, Global Orthopedics · last filed 2024-06-12
Kimberley A. Elting is a President, Global Orthopedics who has filed 38 SEC Form 4 insider transactions across 2 companies since 2015. The most recent filing shows the insider had shares withheld for taxes covering $57.3K of OFIX on Jun 12, 2024. Across all open-market trades the lifetime net is −$397.0K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $2.2M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$2.23M
2
38
-$397.0K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| OFIX | President, Global Orthopedics | 227,747 | $9.78 | $2.23M | -$397.0K | 36 | 2024-06-12 |
| TriVascular Technologies, Inc. (TRIV) Delisted | VP, Gen. Counsel and Secretary | 14,221 | — | — | $0 | 2 | 2016-02-04 |
Recent Filings
38 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-06-12 | OFIX | Tax (F) | −4,267 | -$57.3K | EDGAR |
| 2024-04-12 | OFIX | Tax (F) | −2,938 | -$41.0K | EDGAR |
| 2024-04-03 | OFIX | Tax (F) | −2,031 | -$28.6K | EDGAR |
| 2024-02-05 | OFIX | Tax (F) | −2,015 | -$28.8K | EDGAR |
| 2024-01-09 | OFIX | Mixed | −24,039 | -$316.2K | EDGAR |
| 2024-01-05 | OFIX | Tax (F) | −1,778 | -$23.0K | EDGAR |
| 2023-11-21 | OFIX | Grant (A) | +47,664 | $0 | EDGAR |
| 2023-04-12 | OFIX | Tax (F) | −2,938 | -$52.2K | EDGAR |
| 2023-04-05 | OFIX | Tax (F) | −2,385 | -$39.9K | EDGAR |
| 2023-02-03 | OFIX | Tax (F) | −2,015 | -$43.4K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.